Advances in thymosin β10 research: Differential expression, molecular mechanisms, and clinical implications in cancer and other conditions

Cancer Investigation

Volumn 27, Issue 10, 2009, Pages 1016-1022

  Sribenja, Sirinapa ^a,b   Li, Min ^a   Wongkham, Sopit ^b   Wongkham, Chaisiri ^b   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Actin; Angiogenesis; Apoptosis; Cancer; Thymosin beta 10; Thymosin beta 4

Indexed keywords

ACTIN BINDING PROTEIN; ANTIINFECTIVE AGENT; GROWTH FACTOR; RAS PROTEIN; RETINOIC ACID; RETINOID; THYMOSIN BETA10; ACTIN; THYMOSIN; THYMOSIN BETA(10);

APOPTOSIS; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DRUG MECHANISM; DRUG RESEARCH; EMBRYO DEVELOPMENT; GENE CONTROL; HUMAN; INFLAMMATION; NEOPLASM; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; CANCER INVASION; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; VASCULARIZATION;

ACTINS; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEUROGENESIS; NEURONS; SIGNAL TRANSDUCTION; THYMOSIN; WOUND HEALING;

EID: 70450218162     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902849640     Document Type: Review

References (88)

1. Chen, C.; Li, M.; Yang, H.; Chai, H.; Fisher, W.; Yao, Q. Roles of thymosins in cancers and other organ systems. World J Surg 2005, 29, 264-270. (Pubitemid 40768035)
2. Huff, T.; Muller, C.S.; Otto, A.M.; Netzker, R.; Hannappel, E. Betathymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 2001, 33, 205-220.
3. Goldstein, A.L. History of the discovery of the thymosins. Ann NY Acad Sci 2007, 1112, 1-13.
4. Hannappel, E. Beta-thymosins. Ann NY Acad Sci 2007, 1112, 21-37.
5. Haritos, A.A.; Yialouris, P.P.; Heimer, E.P.; Felix, A.M.; Rosemeyer, M.A. On the molecular size of thymosins. FEBS Lett 1987, 218, 107-112.
6. Hannappel, E.; Huff, T. The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam Horm 2003, 66, 257-296.
7. Tsitsiloni,O.E.; Yialouris, P.P.; Echner, H.; Voelter,W.; Haritos, A.A. Evidence for the extranuclear localization of thymosins in thymus. Experientia 1992, 48, 398-402.
8. Huff, T.; Rosorius, O.; Otto, A.M.; Müller, C.S.; Ballweber, E.; Hannappel, E.; Mannherz, H.G. Nuclear localisation of the G-actin sequestering peptide thymosin beta4. J Cell Sci 2004, 117, 5333-5341.
9. Huff, T.; Zerzawy, D.; Hannappel, E. Interactions of beta-thymosins, thymosin beta 4-sulfoxide, and N-terminally truncated thymosin beta 4 with actin studied by equilibrium centrifugation, chemical cross-linking and viscometry. Eur J Biochem 1995, 230, 650-657.
10. Golla, R.; Philp, N.; Safer, D.; Chintapalli, J.; Hoffman, R.; Collins, L.; Nachmias, V.T. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta4. Cell Motil Cytoskeleton 1997, 38, 187-200.
11. Sun, H.Q.; Yin, H.L. The beta-thymosin enigma. Ann NY Acad Sci 2007, 1112, 45-55.
12. Low, T.L.; Thurman, G.B.; McAdoo, M.; McClure, J.; Rossio, J.L.; Naylor, P.H.; Goldstein, A.L. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J Biol Chem 1979, 254, 981-986.
13. Low, T.L.; Goldstein, A.L. Chemical characterization of thymosin beta 4. J Biol Chem1982, 257, 1000-1006.
14. Yu, F.X.; Lin, S.C.; Morrison-Bogorad, M.; Atkinson, M.A.; Yin, H.L. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem 1993, 268, 502-509.
15. Erickson-Viitanen, S.; Ruggieri, S.; Natalini, P.; Horecker, B.L. Thymosin beta 10, a new analog of thymosin beta 4 in mammalian tissues. Arch Biochem Biophys 1983, 225, 407-413.
16. Santelli, G.; Califano, D.; Chiappetta, G.; Vento, M.T.; Bartoli, P.C.; Zullo, F.; Trapasso, F.; Viglietto, G.; Fusco, A. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 1999, 155, 799-804.
17. Liu, C.R.; Ma, C.S.; Ning, J.Y.; You, J.F.; Liao, S.L.; Zheng, J. Thymosin beta 10 expression and actin filament organization in tumor cell lines with different metastatic potential. Zhonghua Bing Li Xue Za Zhi 2004, 33, 67-71.
18. Hall, A.K. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 1991, 48, 672-677.
19. Hall, A.K. Amplification-independent overexpression of thymosin beta-10 mRNA in human renal cell carcinoma. Ren Fail 1994, 16, 243-254.
20. Weterman, M.A.; van Muijen, G.N.; Ruiter, D.J.; Bloemers, H.P. Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: A new progression marker for human cutaneous melanoma. Int J Cancer 1993, 53, 278-284.
21. Verghese-Nikolakaki, S.; Apostolikas, N.; Livaniou, E.; Ithakissios, D.S.; Evangelatos, G.P. Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Br J Cancer 1996, 74, 1441-1444.
22. Califano, D.; Monaco, C.; Santelli, G.; Giuliano, A.; Veronese, M.L.; Berlingieri, M.T.; de Franciscis, V.; Berger, N.; Trapasso, F.; Santoro, M.; Viglietto, G.; Fusco, A. Thymosin beta-10 gene overexpression correlated with the highlymalignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res 1998, 58, 823-828.
23. Takano, T.; Hasegawa, Y.; Miyauchi, A.; Matsuzuka, F.; Yoshida, H.; Kuma, K.; Amino, N. Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas. Jpn J Clin Oncol 2002, 32, 229-232. (Pubitemid 43102804)
24. Sardi, I.; Tintori, V.;Marchi, C.; Veltroni,M.; Lippi, A.; Tucci, F.; Tamburin, A.; Bernini, G.; Faulkner, L. Molecular profiling of high-risk neuroblastoma by cDNA array. Int J Mol Med 2002, 9, 541-545.
25. Oien, K.A.; Vass, J.K.; Downie, I.; Fullarton, G.; Keith, W.N. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 2003, 22, 4287-4300.
26. Wang, A.G.; Yoon, S.Y.; Oh, J.H.; Jeon, Y.J.; Kim, M.; Kim, J.M.; Byun, S.S.; Yang, J.O.; Kim, J.H.; Kim, D.G.; Yeom, Y.I.; Yoo, H.S.; Kim, Y.S.; Kim, N.S. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun 2006, 345, 1022-1032.
27. Alldinger, I.; Dittert, D.; Peiper, M.; Fusco, A.; Chiappetta, G.; Staub, E.; Lohr, M.; Jesnowski, R.; Baretton, G.; Ockert, D.; Saeger, H.D.; Grützmann, R.; Pilarsky, C. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer. Pancreatology 2005, 5, 370-379.
28. Li, M.; Zhang, Y.; Zhai, Q.; Feurino, L.W.; Fisher, W.E.; Chen, C.; Yao, Q. Thymosin beta 10 is aberrantly expressed in pancreatic cancer and induces JNK activation. Cancer Invest 2009, 27, 251-256.
29. McDoniels-Silvers, A.L.; Nimri, C.F.; Stoner, G.D.; Lubet, R.A.; You, M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002, 8, 1127-1138.
30. Gu, Y.; Wang, C.; Wang, Y.; Qiu, X.; Wang, E. Expression of thymosin beta10 and the role in non-small cell lung cancer. Hum Pathol 2009, 40, 117-124.
31. Lee, S.H.; Zhang, W.; Choi, J.J.; Cho, Y.S.; Oh, S.H.; Kim, J.W.; Hu, L.; Xu, J.; Liu, J.; Lee, J.H. Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Oncogene 2001, 20, 6700-6706.
32. Chiappetta, G.; Pentimalli, F.; Monaco, M.; Fedele, M.; Pasquinelli, R.; Pierantoni, G.M.; Ribecco, M.T.; Santelli, G.; Califano, D.; Pezzullo, L.; Fusco, A. Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias. Oncol Rep 2004, 12, 239-243.
33. Clark, E.A.; Golub, T.R.; Lander, E.S.; Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406, 532-535.
34. Cha, H.J.; Jeong, M.J.; Kleinman, H.K. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 2003, 95, 1674-1680.
35. Gold, J.S.; Bao, L.; Ghoussoub, R.A.; Zetter, B.R.; Rimm, D.L. Localization and quantitation of expression of the cell motilityrelated protein thymosin beta15 in human breast tissue. Mod Pathol 1997, 10, 1106-1112.
36. Bao, L.; Loda, M.; Zetter, B.R. Thymosin beta 15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis 1998, 16, 227-233.
37. Hutchinson, L.M.; Chang, E.L.; Becker, C.M.; Shih, M.C.; Brice, M.; DeWolf, W.C.; Gaston, S.M.; Zetter, B.R. Use of thymosin beta 15 as a urinary biomarker in human prostate cancer. Prostate 2005, 64, 116-127.
38. Liu, Y.; Geng, D.J. Prospects for diagnosis of prostate cancer by biomarkers in the urine. Zhonghua Nan Ke Xue 2006, 12, 453-455.
39. Carpintero, P.; Franco, del. Amo. F.; Anadon, R.; Gomez-Marquez, J. Thymosin beta10 mRNA expression during early postimplantation mouse development. FEBS Lett 1996, 394, 103-106.
40. Lin, S.C.; Morrison-Bogorad, M. Developmental expression of mRNAs encoding thymosins beta 4 and beta 10 in rat brain and other tissues. J Mol Neurosci 1990, 2, 35-44.
41. Voisin, P.J.; Pardue, S.; Morrison-Bogorad, M. Developmental characterization of thymosin beta 4 and beta 10 expression in enriched neuronal cultures from rat cerebella. J Neurochem 1995, 64, 109-120.
42. Anadon, R.; Rodriguez Moldes, I.; Carpintero, P.; Evangelatos, G.; Livianou, E.; Leondiadis, L.; Quintela, I.; Cervino, M.C.; Ǵomez- Ḿarquez, J. Differential expression of thymosins beta (4) and beta (10) during rat cerebellum postnatal development. Brain Res 2001, 894, 255-265.
43. Lugo, D.I.; Chen, S.C.; Hall, A.K.; Ziai, R.; Hempstead, J.L.; Morgan, J.I. Developmental regulation of beta-thymosins in the rat central nervous system. J Neurochem. 1991, 56, 457-461.
44. Carpintero, P.; Anadon, R.; Gomez-Marquez, J. Expression of the thymosin beta10 gene in normal and kainic acid-treated rat forebrain. Brain Res Mol Brain Res 1999, 70, 141-146. (Pubitemid 29278616)
45. Lee, S.H.; Zhao, S.H.; Recknor, J.C.; Nettleton, D.; Orley, S.; Kang, S.K.; Lee, B.C.; Hwang, W.S.; Tuggle, C.K. Transcriptional profiling using a novel cDNA array identifies differential gene expression during porcine embryo elongation. Mol Reprod Dev 2005, 71, 129-139.
46. Hall, A.K.; Hempstead, J.; Morgan, J.I. Thymosin beta 10 levels in developing human brain and its regulation by retinoic acid in the HTB-10 neuroblastoma. Brain Res Mol Brain Res 1990, 8, 129-135.
47. Hall, A.K. Developmental regulation of thymosin beta 10 mRNA in the human brain. Brain Res Mol Brain Res 1991, 9, 175-177.
48. Nakanishi, F.; Ohkawa, K.; Ishida, H.; Hosui, A.; Sato, A.; Hiramatsu, N.; Ueda, K.; Takehara, T.; Kasahara, A.; Sasaki, Y.; Hori, M.; Hayashi, N. Alteration in gene expression profile by full-length hepatitis B virus genome. Intervirology 2005, 48, 77-83.
49. Johansson, U.; Olsson, A.; Gabrielsson, S.; Nilsson, B.; Korsgren, O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003, 308, 474-479.
50. Ka, S.M.; Rifai, A.; Chen, J.H.; Cheng, C.W.; Shui, H.A.; Lee, H.S.; Lin, Y.F.; Hsu, L.F.; Chen, A. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant 2006, 21, 288-298.
51. Tsuji, M.; Monkawa, T.; Yoshino, J.; Asai, M.; Fukuda, S.; Kawachi, H,; Shimizu, F.; Hayashi, M.; Saruta, T. Microarray analysis of a reversible model and an irreversible model of anti-Thy-1 nephritis. Kidney Int 2006, 69, 996-1004.
52. Lapteva, N.; Ando, Y.; Nieda, M.; Hohjoh, H.; Okai, M.; Kikuchi, A.; Dymshits, G.; Ishikawa, Y.; Juji, T.; Tokunaga, K. Profiling of genes expressed in human monocytes and monocyte-derived dendritic cells using cDNA expression array. Br J Haematol 2001, 114, 191-197. (Pubitemid 32702655)
53. Gutierrez-Pabello, J.A.; McMurray, D.N.; Adams, L.G. Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis. Infect Immun 2002, 70, 2121-2127.
54. Eadie, J.S.; Kim, S.W.; Allen, P.G.; Hutchinson, L.M.; Kantor, J.D.; Zetter, B.R. C-terminal variations in beta-thymosin family members specify functional differences in actin-binding properties. J Cell Biochem 2000, 77, 277-287.
55. Huff, T.; Muller, C.S.; Hannappel, E. C-terminal truncation of thymosin beta10 by an intracellular protease and its influence on the interaction with G-actin studied by ultrafiltration. FEBS Lett 1997, 414, 39-44.
56. Safer, D.; Nachmias, V.T. Beta thymosins as actin binding peptides. Bioessays 1994, 16, 473-1449
57. Xue, B.; Aguda, A.H.; Robinson, R.C. Models of the actin-bound forms of the beta-thymosins. Ann NY Acad Sci 2007, 1112, 56-66.
58. Hertzog, M.; van Heijenoort, C.; Didry, D.; Gaudier, M.; Coutant, J.; Gigant, B.; Didelot, G.; Pŕeat, T. Knossow, M.; Guittet, E.; Carlier, M.F. The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assembly. Cell 2004, 117, 611-623.
59. Irobi, E.; Aguda, A.H.; Larsson, M.; Guerin, C.; Yin, H.L.; Burtnick, L.D.; Blanchoin, L.; Robinson, R.C. Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins. EMBO J 2004, 23, 3599-3608.
60. Aguda, A.H.; Xue, B.; Irobi, E.; Pŕeat, T. ; Robinson, R.C. The structural basis of actin interaction with multiple WH2/beta-thymosin motif-containing proteins. Structure 2006, 14, 469-476.
61. Dominguez, R. The beta-thymosin/WH2 fold: Multifunctionality and structure. Ann NY Acad Sci 2007, 1112, 86-94.
62. Yu, F.X.; Lin, S.C.; Morrison-Bogorad, M.; Yin, H.L. Effects of thymosin beta 4 and thymosin beta 10 on actin structures in living cells. Cell Motil Cytoskeleton 1994, 27, 13-25.
63. Sun, H.Q.; Kwiatkowska, K.; Yin, H.L. Beta-thymosins are not simple actin monomer buffering proteins. Insights from overexpression studies. J Biol Chem 1996, 271, 9223-9230.
64. Lin, S.C.; Morrison-Bogorad, M. Cloning and characterization of a testis-specific thymosin beta 10 cDNA. Expression in post-meiotic male germ cells. J Biol Chem 1991, 266, 23347-23353.
65. Maelan, A.E.; Rasmussen, T.K.; Larsson, L.I. Localization of thymosin beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility. Histochem Cell Biol 2007, 127, 109-113.
66. Lee, S.H.; Son, M.J.; Oh, S.H.; Rho, S.B.; Park, K.; Kim, Y.J.; Park, M.S.; Lee, J.H. Thymosin beta 10 inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res 2005, 65, 137-148.
67. Koutrafouri, V.; Leondiadis, L.; Avgoustakis, K.; Livaniou, E.; Czarnecki, J.; Ithakissios, D.S.; Evangelatos, G.P. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim Biophys Acta 2001, 1568, 60-66.
68. Smart, N.; Rossdeutsch, A.; Riley, P.R. Thymosin beta4 and angiogenesis: Modes of action and therapeutic potential. Angiogenesis 2007, 10, 229-241.
69. Mu, H.; Ohashi, R.; Yang, H.; Wang, X.; Li, M.; Lin, P.; Yao, Q. Chen, C. Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells. Cell Motil Cytoskeleton 2006, 63, 222-230.
70. Vasile, E.; Tomita, Y.; Brown, L.F.; Kocher, O.; Dvorak, H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 2001, 15, 458-466.
71. van Kesteren, R.E.; Carter, C.; Dissel, H.M.; van Minnen, J.; Gouwenberg, Y.; Syed, N.I.; Spencer, G.E.; Smit, A.B. Local synthesis of actin-binding protein beta-thymosin regulates neurite outgrowth. J Neurosci 2006, 26, 152-157.
72. Santelli, G.; Bartoli, P.C.; Giuliano, A.; Porcellini, A.; Mineo, A.; Barone, M.V.; Busiello, I.; Trapasso, F.; Califano, D.; Fusco, A. Thymosin beta-10 protein synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid medium. Thyroid 2002, 12, 765-772.
73. Hall, A.K. Thymosin beta-10 accelerates apoptosis. Cell Mol Biol Res 1995, 41, 167-180.
74. Choi, S.Y.; Kim, D.K.; Eun, B.; Kim, D.K.; Eun, B.; Kim, K.; Sun, W.; Kim, H. Anti-apoptotic function of thymosin-beta in developing chick spinal motoneurons. Biochem Biophys Res Commun 2006, 346, 872-878.
75. Hall, A.K. Molecular interactions between G-actin, DNase I and the beta-thymosins in apoptosis: A hypothesis. Med Hypotheses 1994, 43, 125-131.
76. Rho, S.B.; Chun, T.; Lee, S.H.; Park, K.; Lee, J.H. The interaction between E-tropomodulin and thymosin beta-10 rescues tumor cells from thymosin beta-10 mediated apoptosis by restoring actin architecture. FEBS Lett 2004, 557, 57-63.
77. Rho, S.B.; Lee, K.W.; Chun, T.; Lee, S.H.; Park, K.; Lee, J.H. The identification of apoptosis-related residues in human thymosin beta-10 by mutational analysis and computational modeling. J Biol Chem 2005, 280, 34003-34007.
78. Sosne, G.; Siddiqi, A.; Kurpakus-Wheater, M. Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci 2004, 45, 1095-1100.
79. Vassiliadou, I.; Leondiadis, L.; Ferderigos, N.; Ithakissios, D.S.; Evangelatos, G.P.; Livaniou, E. Investigation of the epitopic structure of thymosin beta10 by epitope mapping experiments. Peptides 1999, 20, 411-414.
80. Hutchinson, L.M.; Chang, E.L.; Becker, C.M.; Ushiyama, N.; Behonick, D.; Shih, M.C.; DeWolf, W.C.; Gaston, S.M.; Zetter, B.R. Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. Clin Biochem 2005, 38, 558-571.
81. Hall, A.K.; Chen, S.C.; Hempstead, J.L.; Morgan, J.I. Retinoic acid regulates thymosin beta 10 levels in rat neuroblastoma cells. J Neurochem 1991, 56, 462-468.
82. Hall, A.K. Influence of cyclic AMP and serum factors upon expression of a retinoid-responsive gene in neuroblastoma cells. J Mol Neurosci 1992, 3, 155-163.
83. Hall, A.K. Retinoids and a retinoic acid receptor differentially modulate thymosin beta 10 gene expression in transfected neuroblastoma cells. Cell Mol Neurobiol 1992, 12, 45-58.
84. Pedersen, M.W.; Thykjaer, T.; Orntoft, T.F.; Damstrup, L.; Poulsen, H.S. Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line. Br J Cancer 2001, 85, 1211-1218.
85. Viglietto, G.; Califano, D.; Bruni, P.; Baldassarre, G.; Vento, M.T.; Belletti, B.; Fedele, M.; Santelli, G.; Boccia, A.; Manzo, G.; Santoro, M.; Fusco, A. Regulation of thymosin beta10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes. Eur J Endocrinol 1999, 140, 597-607.
86. Otto, A.M.; Muller, C.S.; Huff, T.; Hannappel, E. Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. J Cancer Res Clin Oncol2002, 128, 247-256.
87. Tanaka, H.; Ohshima, N.; Hidaka, H. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure: drug-western. Mol Pharmacol. 1999, 55, 356-363.
88. Huang, C.M.; Wang, C.C.; Barnes, S.; Elmets, C.A. In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics 2006, 6, 5805-5814.